Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Ludwig

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Cancer Chemotherapy and Pharmacology|January 8, 2021
Concentration-QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemiaDongwoo Kang, Elizabeth Ludwig, David Jaworowicz, et al.
Journal of Clinical Pharmacology|June 30, 2020
Population Pharmacokinetic Analysis of Quizartinib in Healthy Volunteers and Patients With Relapsed/Refractory Acute Myeloid LeukemiaDongwoo Kang, Elizabeth Ludwig, David Jaworowicz, et al.
Clinical Pharmacology and Therapeutics|June 24, 2025
Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart DiseaseAntoinette Ajavon-Hartmann, Praneeth Jarugula, Hyunmoon Back, et al.
JAMA Pediatrics|October 12, 2020
Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York CityDani Dumitriu, Ukachi N Emeruwa, Erin Hanft, et al.
MMWR. Morbidity and Mortality Weekly Report|January 20, 2022
Zika-Associated Birth Defects Reported in Pregnancies with Laboratory Evidence of Confirmed or Possible Zika Virus Infection - U.S. Zika Pregnancy and Infant Registry, December 1, 2015-March 31, 2018Nicole M Roth, Megan R Reynolds, Elizabeth L Lewis, et al.
Pediatric Research|September 1, 2023
Outcomes up to age 36 months after congenital Zika virus infection-U.S. statesVarsha Neelam, Kate R Woodworth, Daniel J Chang, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Cancer Chemotherapy and Pharmacology|January 8, 2021
Concentration-QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemiaDongwoo Kang, Elizabeth Ludwig, David Jaworowicz, et al.
Journal of Clinical Pharmacology|June 30, 2020
Population Pharmacokinetic Analysis of Quizartinib in Healthy Volunteers and Patients With Relapsed/Refractory Acute Myeloid LeukemiaDongwoo Kang, Elizabeth Ludwig, David Jaworowicz, et al.
Clinical Pharmacology and Therapeutics|June 24, 2025
Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart DiseaseAntoinette Ajavon-Hartmann, Praneeth Jarugula, Hyunmoon Back, et al.
JAMA Pediatrics|October 12, 2020
Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York CityDani Dumitriu, Ukachi N Emeruwa, Erin Hanft, et al.
MMWR. Morbidity and Mortality Weekly Report|January 20, 2022
Zika-Associated Birth Defects Reported in Pregnancies with Laboratory Evidence of Confirmed or Possible Zika Virus Infection - U.S. Zika Pregnancy and Infant Registry, December 1, 2015-March 31, 2018Nicole M Roth, Megan R Reynolds, Elizabeth L Lewis, et al.
Pediatric Research|September 1, 2023
Outcomes up to age 36 months after congenital Zika virus infection-U.S. statesVarsha Neelam, Kate R Woodworth, Daniel J Chang, et al.
Pageof 4